Insider Trading & Ownership of Edward Morrow Atkinson III

Location
San Francisco, CA
Summary
The estimated net worth of Edward Morrow Atkinson III is at least $8,964,403 dollars as of 26 Feb 2026. Edward Morrow Atkinson III is the EVP, Chief Technical Ops. Off. of VERTEX PHARMACEUTICALS INC / MA and owns shares of VERTEX PHARMACEUTICALS INC / MA (VRTX) stock worth about $8.96M.
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Edward Morrow Atkinson III and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • Edward Morrow Atkinson III has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $8,964,403.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: VERTEX PHARMACEUTICALS INC / MA ($8,964,403).
  • Past-year value change for that position: -$3,598,635.

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Edward Morrow Atkinson III

ETNB Forms 3/4/5

89bio, Inc.

Relationship
Director
Holdings value
Past year net change
Change %
Report period
30 Oct 2025

Insider Transactions Reported by Edward Morrow Atkinson III:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .